Cargando…

Myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the MAP2K2-dependent ERK pathway

BACKGROUND: The dysfunction of myc-related zinc finger protein (MAZ) has been proven to contribute to tumorigenesis and development of multiple cancer types. However, the biological roles and clinical significance of MAZ in clear cell renal carcinoma (ccRCC) remain unclear. METHODS: MAZ expression w...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Li-Xin, Qi, Jin-Chun, Zhao, An-Ning, Shi, Bei, Zhang, Hong, Wang, Dan-Dan, Yang, Zhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240279/
https://www.ncbi.nlm.nih.gov/pubmed/34183010
http://dx.doi.org/10.1186/s12935-021-02020-9
_version_ 1783715182366687232
author Ren, Li-Xin
Qi, Jin-Chun
Zhao, An-Ning
Shi, Bei
Zhang, Hong
Wang, Dan-Dan
Yang, Zhan
author_facet Ren, Li-Xin
Qi, Jin-Chun
Zhao, An-Ning
Shi, Bei
Zhang, Hong
Wang, Dan-Dan
Yang, Zhan
author_sort Ren, Li-Xin
collection PubMed
description BACKGROUND: The dysfunction of myc-related zinc finger protein (MAZ) has been proven to contribute to tumorigenesis and development of multiple cancer types. However, the biological roles and clinical significance of MAZ in clear cell renal carcinoma (ccRCC) remain unclear. METHODS: MAZ expression was examined in ccRCC and normal kidney tissue by quantitative real-time PCR and Western blot. Statistical analysis was used to evaluate the clinical correlation between MAZ expression and clinicopathological characteristics to determine the relationship between MAZ expression and the survival of ccRCC patients. The biological roles of MAZ in cells were investigated in vitro using MTT and colony assays. Luciferase reporter assays and chromatin immunoprecipitation (ChIP) were used to investigate the relationship between MAZ and its potential downstream signaling molecules. RESULTS: MAZ expression is elevated in ccRCC tissues, and higher levels of MAZ were correlated with poor survival of patients with ccRCC. MAZ upregulation elevates the proliferation ability of ccRCC cells in vitro, whereas silencing MAZ represses this ability. Our results further reveal that MAZ promotes cell growth, which is dependent on ERK signaling. Importantly, we found that MAZ positively regulates MAP2K2 expression in ccRCC cells. Mechanistically, MAZ binds to the MAP2K2 promoter and increases MAP2K2 transcription. Furthermore, MAP2K2 levels were shown to be increased in ccRCC tissues and to be associated with a poor prognosis of ccRCC patients. MAP2K2 upregulation activates the ERK signaling pathway and promotes ccRCC progression. CONCLUSION: These results reveal that the MAZ/MAP2K2/ERK signaling axis plays a crucial role in promoting ccRCC progression, which suggests the potential therapeutic utility of MAZ in ccRCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02020-9.
format Online
Article
Text
id pubmed-8240279
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82402792021-06-29 Myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the MAP2K2-dependent ERK pathway Ren, Li-Xin Qi, Jin-Chun Zhao, An-Ning Shi, Bei Zhang, Hong Wang, Dan-Dan Yang, Zhan Cancer Cell Int Primary Research BACKGROUND: The dysfunction of myc-related zinc finger protein (MAZ) has been proven to contribute to tumorigenesis and development of multiple cancer types. However, the biological roles and clinical significance of MAZ in clear cell renal carcinoma (ccRCC) remain unclear. METHODS: MAZ expression was examined in ccRCC and normal kidney tissue by quantitative real-time PCR and Western blot. Statistical analysis was used to evaluate the clinical correlation between MAZ expression and clinicopathological characteristics to determine the relationship between MAZ expression and the survival of ccRCC patients. The biological roles of MAZ in cells were investigated in vitro using MTT and colony assays. Luciferase reporter assays and chromatin immunoprecipitation (ChIP) were used to investigate the relationship between MAZ and its potential downstream signaling molecules. RESULTS: MAZ expression is elevated in ccRCC tissues, and higher levels of MAZ were correlated with poor survival of patients with ccRCC. MAZ upregulation elevates the proliferation ability of ccRCC cells in vitro, whereas silencing MAZ represses this ability. Our results further reveal that MAZ promotes cell growth, which is dependent on ERK signaling. Importantly, we found that MAZ positively regulates MAP2K2 expression in ccRCC cells. Mechanistically, MAZ binds to the MAP2K2 promoter and increases MAP2K2 transcription. Furthermore, MAP2K2 levels were shown to be increased in ccRCC tissues and to be associated with a poor prognosis of ccRCC patients. MAP2K2 upregulation activates the ERK signaling pathway and promotes ccRCC progression. CONCLUSION: These results reveal that the MAZ/MAP2K2/ERK signaling axis plays a crucial role in promoting ccRCC progression, which suggests the potential therapeutic utility of MAZ in ccRCC. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02020-9. BioMed Central 2021-06-28 /pmc/articles/PMC8240279/ /pubmed/34183010 http://dx.doi.org/10.1186/s12935-021-02020-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Primary Research
Ren, Li-Xin
Qi, Jin-Chun
Zhao, An-Ning
Shi, Bei
Zhang, Hong
Wang, Dan-Dan
Yang, Zhan
Myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the MAP2K2-dependent ERK pathway
title Myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the MAP2K2-dependent ERK pathway
title_full Myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the MAP2K2-dependent ERK pathway
title_fullStr Myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the MAP2K2-dependent ERK pathway
title_full_unstemmed Myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the MAP2K2-dependent ERK pathway
title_short Myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the MAP2K2-dependent ERK pathway
title_sort myc-associated zinc-finger protein promotes clear cell renal cell carcinoma progression through transcriptional activation of the map2k2-dependent erk pathway
topic Primary Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240279/
https://www.ncbi.nlm.nih.gov/pubmed/34183010
http://dx.doi.org/10.1186/s12935-021-02020-9
work_keys_str_mv AT renlixin mycassociatedzincfingerproteinpromotesclearcellrenalcellcarcinomaprogressionthroughtranscriptionalactivationofthemap2k2dependenterkpathway
AT qijinchun mycassociatedzincfingerproteinpromotesclearcellrenalcellcarcinomaprogressionthroughtranscriptionalactivationofthemap2k2dependenterkpathway
AT zhaoanning mycassociatedzincfingerproteinpromotesclearcellrenalcellcarcinomaprogressionthroughtranscriptionalactivationofthemap2k2dependenterkpathway
AT shibei mycassociatedzincfingerproteinpromotesclearcellrenalcellcarcinomaprogressionthroughtranscriptionalactivationofthemap2k2dependenterkpathway
AT zhanghong mycassociatedzincfingerproteinpromotesclearcellrenalcellcarcinomaprogressionthroughtranscriptionalactivationofthemap2k2dependenterkpathway
AT wangdandan mycassociatedzincfingerproteinpromotesclearcellrenalcellcarcinomaprogressionthroughtranscriptionalactivationofthemap2k2dependenterkpathway
AT yangzhan mycassociatedzincfingerproteinpromotesclearcellrenalcellcarcinomaprogressionthroughtranscriptionalactivationofthemap2k2dependenterkpathway